Alkermes Reports Second Quarter 2017 Financial Results Post author:Sam Post published:July 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018 Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML September 28, 2017 Orchard Therapeutics Scoops Up $110M in Funding to Advance "Bubble Boy Syndrome" Gene Therapy December 19, 2017
Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018
Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML September 28, 2017
Orchard Therapeutics Scoops Up $110M in Funding to Advance "Bubble Boy Syndrome" Gene Therapy December 19, 2017